Big Tech’s power resources: four eras of corporate influence in the EU
Socio-Economic Review · 06.11.2026
DOI: 10.1093/ser/mwag055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Socio-Economic Review, online erschienen am 06.11.2026. Verfasst von Matti Ylönen und 1 weiteren Autor:innen. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Finland.
Abstract (Originalsprache)
The political clout of Big Tech firms has gained growing attention, as the tech industry has emerged as the largest lobbying force in Brussels. Drawing on a case study based on an extensive round of interviews in Brussels and other research, we argue that Big Tech’s penetration of European politics has proceeded in four overlapping yet distinct phases: harnessing an economic style of reasoning (1990s–2000s), leveraging platform power (2000s–2010s), championing European values (2010s–2020s), and exploiting dependence on American digital infrastructures (late 2020s). Advancing recent theoretical and empirical literature on this front, we show how each period relies on a distinct bundle of power resources. At one end are conventional lobbying techniques and a push for a deregulatory hegemony, while at the other are lobbying and hegemony-building strategies that utilize digital power resources. The findings invite a reassessment of established theories in this field. Policy implications also abound.
Förderung
- Research Council of Finland
Zitieren
APA
Ylönen, M., & Nordström, L. (2026). Big Tech’s power resources: four eras of corporate influence in the EU. Socio-Economic Review. https://doi.org/10.1093/ser/mwag055
Vancouver
Ylönen M, Nordström L. Big Tech’s power resources: four eras of corporate influence in the EU. Socio-Economic Review. 2026. doi:10.1093/ser/mwag055
BibTeX
@article{Ylnen2026,
author = {Ylönen, Matti and Nordström, Laura},
title = {Big Tech’s power resources: four eras of corporate influence in the EU},
journal = {Socio-Economic Review},
year = {2026},
doi = {10.1093/ser/mwag055}
}
EUVIMED